None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Participants willing to give written informed consent.(Annexure 1) 2.Participants of either sex aged between 18 and 60 years. 3.Health care workers -Nurses
Exclusion criteria
Exclusion criteria: Participants who are not willing to give consent for the study. 2. Participants with comorbidities like Hypertension, Type 1 or 2 Diabetes mellitus, 3. Participants suffering from chronic conditions affecting any of the major organs such as, Liver, Kidney, heart and Lungs 4. Pregnant women/lactating mothers 5. Participants on immunosuppressants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Measurement of serum levels of Anti-oxidant biomarkers such as Superoxide dismutase (SOD), Catalase, Malondialdehyde (MDA), Glutathione (GSH) at baseline (Day 0) and Day 15 2. Measurement of serum levels of Immune biomarkers such as IFN-β and IFN- λ at baseline (Day 0) and Day 15 Timepoint: Day 0 and Day 15 | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measure: 1.Number and severity of side-effects if any. Timepoint: Day 15 | — |
Countries
India